| Patent | Date |
|---|
Cannabinoid Receptor Modulators
App 20220241274 - Thatte; Jayant ; et al. | 2022-08-04 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20220002244 - Blackburn; Anthony C. ; et al. | 2022-01-06 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20210380560 - Blackburn; Anthony C. ; et al. | 2021-12-09 |
Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20210340154 - Tran; Thuy-Anh ; et al. | 2021-11-04 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P.sub.1 receptor-associated disorders
Grant 11,091,435 - Blackburn , et al. August 17, 2 | 2021-08-17 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 10,981,895 - Blackburn , et al. April 20, 2 | 2021-04-20 |
Cannabinoid Receptor Modulators
App 20210060040 - Thatte; Jayant ; et al. | 2021-03-04 |
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
Grant 10,927,123 - Tran , et al. February 23, 2 | 2021-02-23 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20200361869 - Blackburn; Anthony C. ; et al. | 2020-11-19 |
Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20200270264 - Tran; Thuy-Anh ; et al. | 2020-08-27 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
Grant 10,676,435 - Blackburn , et al. | 2020-06-09 |
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
Grant 10,662,200 - Tran , et al. | 2020-05-26 |
Cannabinoid receptor modulators
Grant 10,632,134 - Thatte , et al. | 2020-04-28 |
Cannabinoid Receptor Modulators
App 20200069681 - Thatte; Jayant ; et al. | 2020-03-05 |
Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20190389875 - Tran; Thuy-Anh ; et al. | 2019-12-26 |
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto
Grant 10,479,797 - Tran , et al. Nov | 2019-11-19 |
Modified-release dosage forms of 5-HT.sub.2C agonists useful for weight management
Grant 10,463,676 - Shao , et al. No | 2019-11-05 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-
App 20190330153 - Blackburn; Anthony C. ; et al. | 2019-10-31 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20190308952 - Blackburn; Anthony C. ; et al. | 2019-10-10 |
Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20190292196 - Tran; Thuy-Anh ; et al. | 2019-09-26 |
Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20190284200 - Tran; Thuy-Anh ; et al. | 2019-09-19 |
Modified-Release Dosage Forms of 5-Ht2c Agonists Useful for Weight Management
App 20190275055 - Shao; Zezhi Jesse ; et al. | 2019-09-12 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
Grant 10,301,262 - Blackburn , et al. | 2019-05-28 |
Modified-release dosage forms of 5-HT.sub.2C agonists useful for weight management
Grant 10,226,471 - Shao , et al. | 2019-03-12 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 10,183,930 - Blackburn , et al. Ja | 2019-01-22 |
Cannabinoid Receptor Modulators
App 20180280386 - Thatte; Jayant ; et al. | 2018-10-04 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20180186738 - Blackburn; Anthony C. ; et al. | 2018-07-05 |
Cannabinoid receptor modulators
Grant 9,867,822 - Thatte , et al. January 16, 2 | 2018-01-16 |
Cannabinoid Receptor Modulators
App 20170304327 - Thatte; Jayant ; et al. | 2017-10-26 |
Modified-release Dosage Forms Of 5-ht2c Agonists Useful For Weight Management
App 20170246179 - Shao; Zezhi Jesse ; et al. | 2017-08-31 |
Cannabinoid Receptor Modulators
App 20170143704 - Thatte; Jayant ; et al. | 2017-05-25 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20170144993 - Blackburn; Anthony C. ; et al. | 2017-05-25 |
Non-hygroscopic Salts Of 5-ht2c Agonists
App 20170096398 - Blackburn; Anthony C. ; et al. | 2017-04-06 |
Cannabinoid receptor modulators
Grant 9,597,340 - Thatte , et al. March 21, 2 | 2017-03-21 |
Cannabinoid receptor modulators
Grant 9,492,447 - Thatte , et al. November 15, 2 | 2016-11-15 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 9,458,136 - Blackburn , et al. October 4, 2 | 2016-10-04 |
Cannabinoid Receptor Modulators
App 20160271127 - Thatte; Jayant ; et al. | 2016-09-22 |
Non-hygroscopic salts of 5-HT.sub.2C agonists
Grant 9,365,521 - Blackburn , et al. June 14, 2 | 2016-06-14 |
Salts Of Lorcaserin With Optically Active Acids
App 20160151381 - Blackburn; Anthony C. ; et al. | 2016-06-02 |
Salts of lorcaserin with optically active acids
Grant 9,248,133 - Blackburn , et al. February 2, 2 | 2016-02-02 |
Processes for the preparation of 5-HT.sub.2C receptor agonists
Grant 9,045,431 - Blackburn , et al. June 2, 2 | 2015-06-02 |
Cannabinoid Receptor Modulators
App 20150126477 - Thatte; Jayant ; et al. | 2015-05-07 |
Modulators Of The G Protein-coupled Mas Receptor And The Treatment Of Disorders Related Thereto
App 20140309192 - Tran; Thuy-Anh ; et al. | 2014-10-16 |
Cannabinoid Receptor Modulators
App 20140206649 - Thatte; Jayant ; et al. | 2014-07-24 |
Fast-dissolve Dosage Forms Of 5-ht2c Agonists
App 20140148442 - Blackburn; Anthony C. ; et al. | 2014-05-29 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20140135345 - Blackburn; Anthony C. ; et al. | 2014-05-15 |
Modified-release Dosage Forms Of 5-ht2c Agonists Useful For Weight Management
App 20130315994 - Shao; Zezhi Jesse ; et al. | 2013-11-28 |
Non-hygroscopic Salts Of 5-ht2c Agonists
App 20130317005 - Blackburn; Anthony C. ; et al. | 2013-11-28 |
Salts Of Lorcaserin With Optically Active Acids
App 20130310369 - Blackburn; Anthony C. ; et al. | 2013-11-21 |
Processes For The Preparation Of 5-ht2c Receptor Agonists
App 20130158013 - Blackburn; Anthony C. ; et al. | 2013-06-20 |
Crystalline Forms And Processes For The Preparation Of Pg12 Receptor Agonists
App 20120225937 - Blackburn; Anthony C. ; et al. | 2012-09-06 |
Crystalline Forms Of (r)-1-{2-[4`- (3-methoxy-propane-1- Sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, And Compositions, And Methods Related Thereto
App 20100292288 - Blackburn; Anthony C. ; et al. | 2010-11-18 |
| 